Skip to Content

Akoya Biosciences Inc AKYA

Morningstar Rating
$4.69 −0.04 (0.85%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

AKYA is trading at a 33% discount.
Price
$4.89
Fair Value
$2.33
Uncertainty
Extreme
1-Star Price
$54.32
5-Star Price
$3.40
Economic Moat
Fjjzh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AKYA is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$4.73
Day Range
$4.594.79
52-Week Range
$3.048.80
Bid/Ask
$4.69 / $4.71
Market Cap
$230.47 Mil
Volume/Avg
136,367 / 217,830

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.16
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler® (formerly CODEX) and PhenoImager® (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Value
Total Number of Employees
330

Comparables

Valuation

Metric
AKYA
RXRX
AAGH
Price/Earnings (Normalized)
Price/Book Value
4.285.03
Price/Sales
2.1647.23294.00
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
AKYA
RXRX
AAGH
Quick Ratio
2.834.240.03
Current Ratio
3.454.700.08
Interest Coverage
−6.62−3,620.07−1.37
Quick Ratio
AKYA
RXRX
AAGH

Profitability

Metric
AKYA
RXRX
AAGH
Return on Assets (Normalized)
−30.67%−41.77%−281.13%
Return on Equity (Normalized)
−93.26%−59.93%
Return on Invested Capital (Normalized)
−36.71%−57.52%
Return on Assets
AKYA
RXRX
AAGH
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncSzyndwnwgDbly$141.5 Bil
BDX
Becton Dickinson & CoKdzpdbmqXfsfwz$71.5 Bil
ALC
Alcon IncFxjwwyhlQzvsg$40.7 Bil
CLPBY
Coloplast A/S ADRXdscjhpfNqxt$30.4 Bil
RMD
ResMed IncPkdqcvzwggCmfkcf$29.1 Bil
WST
West Pharmaceutical Services IncFjwncnwjptMjlh$29.0 Bil
BAX
Baxter International IncFgtcxgggBhmgm$21.8 Bil
COO
The Cooper Companies IncLkchnqgRjbgby$20.2 Bil
HOLX
Hologic IncLtcbzcrLdfjhrl$18.3 Bil
TFX
Teleflex IncMdjbgTmvhk$10.6 Bil

Sponsor Center